Curatis Holding (SWX:CURN) Stock Sees Revenue Progress But Loss Risk Lingers

Curatis Holding came into this earnings print with a bruised share price over the past three months and a volatile chart, yet the latest half-year numbers tell a more measured story. The stock closed at CHF19.15 on 22 September, while the business continued to post losses but paired that with higher reported revenue of CHF7.94 million for the first half of 2026.

The real headline is the profit squeeze. Curatis Holding recorded a net loss of CHF0.407 million for H1 and basic earnings per share stayed in negative territory at CHF0.07841. This keeps the investment case firmly focused on how long the balance sheet can support the current valuation.

Like the revenue story at Curatis Holding but uneasy about ongoing losses and balance sheet risk? Consider balancing this kind of profile with our list of solid balance sheet and fundamentals stocks (198 results).

H1 2026 Earnings Summary

• Revenue (H1 2026 vs. H1 2025): CHF7.94 million vs. CHF5.243 million (higher top line for the latest half year)
• Net Loss (H1 2026 vs. H1 2025): CHF0.407 million loss vs. CHF1.165 million loss (smaller loss in the current period)
• Basic EPS (H1 2026 vs. H1 2025): CHF0.07841 loss per share vs. CHF0.235057 loss per share (lower loss per share for H1 2026)
• Trailing 12-month Revenue (to H1 2026 vs. to H1 2025): CHF13.497 million vs. CHF10.16 million (top line was 32.8% higher over the last 12 months)

Tired of scrolling through walls of earnings tables and raw figures trying to piece the story together yourself? See Curatis Holding’s full financial picture, including a clear view of its recent losses and profitability trend, in an interactive visual format with our company report for Curatis Holding.

Curatis bullish story leans on improving loss profile

For anyone leaning positive on Curatis Holding, the latest half year gives some support. Revenue for H1 2026 sits at CHF7.94 million, ahead of the prior period, while the net loss narrowed to CHF0.407 million. That mix suggests the commercial platform is adding scale without a parallel blowout in costs. With trailing 12 month revenue at CHF13.497 million, the business is starting to look more like a functioning specialty pharma platform than a pure early stage pipeline bet.

Losses and share slide keep Curatis risk in focus

The bearish story has not vanished. Curatis Holding still reports a half year loss and earnings per share remain negative, which keeps funding and dilution worries alive for a development heavy pharma group. The share price has fallen about 13% over 90 days, which points to ongoing caution. Even with revenue higher and losses smaller than in H1 2025, the data still frame this as a company where execution and balance sheet strength matter as much as scientific progress.

After a 13% slide in three months and continuing losses, volatility at Curatis Holding may reflect deeper fault lines. Review the full risk analysis for Curatis Holding which shows 1 important warning sign

Take Control Of Your Next Move

Curatis Holding just reported higher revenue alongside continuing losses, which makes timing your entry point especially important, so register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value before you act. After you own it, use the Portfolio Command Center to cut through market noise and focus on the key alerts that matter for your holdings. For longer term conviction, lean on the Community to see how other investors are thinking about the same risks and potential catalysts. By spotting hidden drivers and pressure points early, you may give yourself a better chance of staying ahead of the wider market.

Seeking Alternatives Beyond Curatis Holding?

Fresh ideas keep moving while you read. Some are building breakout momentum, others are dropping into rare value territory. Spot them before the crowd notices and get in early.

• Charge toward potential income resilience by scanning companies that aim to shield payouts in rough markets through our curated 159 dividend fortresses.
• Hunt for future-facing infrastructure players by reviewing our hand picked 86 AI infrastructure stocks that could support the backbone of growing data and compute demand.
• Track real world assets with scarcity appeal by checking a carefully filtered group in the 35 best rare earth metal stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com